WEI

Advertisement
Dec 22 2024SPORTS

Usyk's Big Win: A Rematch Triumph

In a thrilling boxing match, Ukrainian champ Oleksandr Usyk defended his heavyweight titles against Britain's Tyson Fury. Despite being smaller, Usyk used his speed and skill to outmaneuver the taller Fury. The fight was a back-and-forth battle, with Fury trying to control the ring and Usyk counteri

reading time less than a minute
Dec 21 2024HEALTH

Sleep Apnoea Treatment Gets New Drug Approval

Big news! The US Food and Drug Administration has given the go-ahead for Eli Lilly's new drug, Zepbound, to treat adults with both sleep apnoea and obesity. This could be a game-changer for the company, as it looks to expand its successful weight-loss drug business. The drug was shown to significant

reading time less than a minute
Dec 21 2024SPORTS

Boxing Rematch: Usyk vs Fury - AI Picks the Winner

The big night is almost here! The much-awaited rematch between Oleksandr Usyk and Tyson Fury is just around the corner. Opinions are divided among boxing greats about who will come out on top. IBF heavyweight champion Daniel Dubois is rooting for Fury, while fellow Brits Anthony Joshua and Lennox Le

reading time less than a minute
Dec 21 2024CELEBRITIES

Diddy's Court Appearance Reveals Transformations in His Look and Life

It's been a tough year for Diddy. After being arrested last September on charges of sex trafficking and racketeering, he's been waiting behind bars for his trial set to start in May 2025. To make things worse, the Bad Boy Records founder is also facing several lawsuits involving allegations of sexua

reading time less than a minute
Dec 20 2024BUSINESS

Novo Nordisk's New Weight-Loss Drug Fails to Impress Investors

Novo Nordisk, a big player in Europe's pharma scene, saw its shares take a huge hit on Friday. Why? Their latest weight-loss drug, CagriSema, didn't meet expectations. The drug helped patients lose about 22. 7% of their body weight in late-stage trials, but that was barely better than Eli Lilly's ri

reading time less than a minute
Dec 20 2024HEALTH

No More Shortages: FDA Clears Lilly's Weight-Loss Drug

The U. S. Food and Drug Administration (FDA) announced that there are no longer shortages of Eli Lilly’s popular weight-loss and diabetes drugs. This decision stops the widespread sale of cheaper, unapproved copies made by compounding pharmacies. The FDA will not take action against these pharmacies

reading time less than a minute
Dec 19 2024TECHNOLOGY

Apple's AI in China: A New Twist

Apple is in talks with major Chinese tech companies Tencent and ByteDance to bring its advanced AI features to iPhones sold in China. The main challenge? Meeting Chinese regulations for AI services, like Apple's newly integrated OpenAI's ChatGPT. This tool enhances Siri but isn't available in China

reading time less than a minute
Dec 19 2024TECHNOLOGY

Wearables on the Move: HUAWEI Surprises, Apple Stumbles

This year, something surprising happened in the world of wearables. According to new data, the total number of wrist-worn devices reached 139 million units worldwide. That's a minor dip from last year, but there's an interesting twist – HUAWEI replaced Apple as the top brand for overall wrist-worn s

reading time less than a minute
Dec 18 2024HEALTH

Walking with Weights: How Stroke Survivors Handle the Extra Load

You might think adding weights to your arms while walking is a good way to improve mobility after a stroke. But is it safe? Researchers tested this idea with nine stroke survivors. Each person walked under four conditions: no weights, weights on their stronger side, weights on their weaker side, and

reading time less than a minute
Dec 18 2024HEALTH

--weights drugs spark healthcare visits

These days, there's a buzz about certain weight-loss drugs like Ozempic, Wegovy, and Zepbound. A recent study by health data company Truveta found that people taking these drugs often end up seeing their doctor more. This isn't just about slimming down; it's also leading to diagnoses of other relate

reading time less than a minute